• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

随机临床试验中患者亚组治疗效果的分析与解读。

Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials.

作者信息

Yusuf S, Wittes J, Probstfield J, Tyroler H A

机构信息

Division of Epidemiology and Clinical Applications, National Heart, Lung, and Blood Institute, Bethesda, Md 20892.

出版信息

JAMA. 1991 Jul 3;266(1):93-8.

PMID:2046134
Abstract

A key principle for interpretation of subgroup results is that quantitative interactions (differences in degree) are much more likely than qualitative interactions (differences in kind). Quantitative interactions are likely to be truly present whether or not they are apparent, whereas apparent qualitative interactions should generally be disbelieved as they have usually not been replicated consistently. Therefore, the overall trial result is usually a better guide to the direction of effect in subgroups than the apparent effect observed within a subgroup. Failure to specify prior hypotheses, to account for multiple comparisons, or to correct P values increases the chance of finding spurious subgroup effects. Conversely, inadequate sample size, classification of patients into the wrong subgroup, and low power of tests of interaction make finding true subgroup effects difficult. We recommend examining the architecture of the entire set of subgroups within a trial, analyzing similar subgroups across independent trials, and interpreting the evidence in the context of known biologic mechanisms and patient prognosis.

摘要

亚组结果解释的一个关键原则是,定量相互作用(程度差异)比定性相互作用(性质差异)更有可能出现。无论定量相互作用是否明显,它们都可能真实存在,而明显的定性相互作用通常不应被采信,因为它们通常未得到一致的重复验证。因此,总体试验结果通常比亚组内观察到的明显效应更能指导亚组效应的方向。未预先设定假设、未考虑多重比较或未校正P值会增加发现虚假亚组效应的可能性。相反,样本量不足、将患者错误分类到亚组以及相互作用检验效能低会使发现真正的亚组效应变得困难。我们建议检查试验中亚组的整体架构,分析独立试验中的相似亚组,并结合已知的生物学机制和患者预后对证据进行解释。

相似文献

1
Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials.随机临床试验中患者亚组治疗效果的分析与解读。
JAMA. 1991 Jul 3;266(1):93-8.
2
Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.随机对照试验中的亚组分析:量化假阳性和假阴性风险
Health Technol Assess. 2001;5(33):1-56. doi: 10.3310/hta5330.
3
Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading?治疗性心血管临床试验中的亚组分析:它们大多具有误导性吗?
Am Heart J. 2006 Feb;151(2):257-64. doi: 10.1016/j.ahj.2005.04.020.
4
Subgroups, treatment effects, and baseline risks: some lessons from major cardiovascular trials.亚组、治疗效果和基线风险:主要心血管试验的一些经验教训。
Am Heart J. 2000 Jun;139(6):952-61. doi: 10.1067/mhj.2000.106610.
5
Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.跨国临床试验中亚组分析的挑战:来自MERIT-HF试验的经验
Am Heart J. 2001 Sep;142(3):502-11. doi: 10.1067/mhj.2001.117600.
6
Primer: the fallacy of subgroup analysis.入门知识:亚组分析的谬误
Nat Clin Pract Rheumatol. 2007 Jul;3(7):407-13. doi: 10.1038/ncprheum0528.
7
Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test.随机试验中的亚组分析:亚组特异性分析的风险;交互作用检验的效能和样本量
J Clin Epidemiol. 2004 Mar;57(3):229-36. doi: 10.1016/j.jclinepi.2003.08.009.
8
Rudiments of subgroup analyses.亚组分析基础。
Prog Cardiovasc Dis. 2012 Jan-Feb;54(4):338-42. doi: 10.1016/j.pcad.2011.07.005.
9
Tutorial on statistical considerations on subgroup analysis in confirmatory clinical trials.确证性临床试验中亚组分析的统计学考量教程。
Stat Med. 2017 Apr 15;36(8):1334-1360. doi: 10.1002/sim.7167. Epub 2016 Nov 28.
10
Subgroup analysis and interpretation for phase 3 confirmatory trials: White paper of the EFSPI/PSI working group on subgroup analysis.3期确证性试验的亚组分析与解读:EFSPI/PSI亚组分析工作组白皮书
Pharm Stat. 2019 Mar;18(2):126-139. doi: 10.1002/pst.1919. Epub 2018 Dec 27.

引用本文的文献

1
Pancancer outcome prediction via a unified weakly supervised deep learning model.通过统一的弱监督深度学习模型进行泛癌结果预测。
Signal Transduct Target Ther. 2025 Sep 3;10(1):285. doi: 10.1038/s41392-025-02374-w.
2
Predictive Modeling of Heterogeneous Treatment Effects in RCTs: A Scoping Review.随机对照试验中异质性治疗效果的预测建模:一项范围综述
JAMA Netw Open. 2025 Jul 1;8(7):e2522390. doi: 10.1001/jamanetworkopen.2025.22390.
3
A Perspective on the Appropriate Implementation of ICH E9(R1) Addendum Strategies for Handling Intercurrent Events.
关于妥善实施《国际人用药品注册技术协调会E9(R1)增编:处理并发事件的策略》的观点
Stat Med. 2025 May;44(10-12):e70104. doi: 10.1002/sim.70104.
4
CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials.CONSORT 2025解释与阐述:随机对照试验报告的更新指南
BMJ. 2025 Apr 14;389:e081124. doi: 10.1136/bmj-2024-081124.
5
Balloon dilatation of the Eustachian tube for obstructive Eustachian tube dysfunction in adults.成人咽鼓管阻塞性功能障碍的咽鼓管球囊扩张术。
Cochrane Database Syst Rev. 2025 Feb 26;2(2):CD013429. doi: 10.1002/14651858.CD013429.pub2.
6
Heterogeneity in meta-analyses: an unavoidable challenge worth exploring.Meta分析中的异质性:一个值得探索的不可避免的挑战。
Korean J Anesthesiol. 2025 Aug;78(4):301-314. doi: 10.4097/kja.25001. Epub 2025 Feb 14.
7
Systematic evaluation of subgroup analyses of inhaled treprostinil in pulmonary hypertension due to interstitial lung disease.对吸入性曲前列尼尔用于治疗间质性肺疾病所致肺动脉高压亚组分析的系统评价。
PLoS One. 2025 Feb 12;20(2):e0318739. doi: 10.1371/journal.pone.0318739. eCollection 2025.
8
Authors' Reply: Proton Pump Inhibitors May Cause a Decline in eGFR by Inhibiting Organic Cation Transporter 2-Dependent Creatinine Secretion.作者回复:质子泵抑制剂可能通过抑制有机阳离子转运体2依赖性肌酐分泌导致估算肾小球滤过率下降。
J Am Soc Nephrol. 2024 Nov 1;35(11):1614. doi: 10.1681/ASN.0000000000000464. Epub 2024 Aug 19.
9
Long-Term Outcomes of Transcatheter vs Surgical Aortic Valve Replacement: Meta-analysis of Randomized Trials.经导管与外科主动脉瓣置换术的长期结局:随机试验的荟萃分析
J Soc Cardiovasc Angiogr Interv. 2024 May 15;3(7):102143. doi: 10.1016/j.jscai.2024.102143. eCollection 2024 Jul.
10
Interaction analysis of subgroup effects in randomized trials: the essential methodological points.随机试验亚组效应的交互作用分析:基本方法要点。
Sci Rep. 2024 Jun 1;14(1):12619. doi: 10.1038/s41598-024-62896-1.